Catheter Precision, Inc. Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent
Catheter Precision, Inc. (VTAK) had Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent of $15.38 million as of 2017-12-31, per its 10-K filed 2019-03-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent · last filed 2019-03-15
- 2017-12-31: Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent $15.38M.
| Period end | Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent |
|---|---|
| 2017-12-31 | $15.38M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |